Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2027-08-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the clinical efficacy and safety of anlotinib in combination with penpulimab and conventional chemoradiotherapy for the neoadjuvant treatment of locally advanced rectal cancer
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University